Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

The Original Article was published on 30 April 2018

Correction to: Nature Medicine https://doi.org/10.1038/s41591-018-0016-8, published online 30 April 2018.

In the version of this article originally published, an asterisk was omitted from Fig. 1a. The asterisk has been added to the figure.

Fig. 1a
figure1

Original and corrected.

Additionally, a “NOTCH2” label was erroneously included in Fig. 4a. The label has been removed.

Fig. 4a
figure4

Original and corrected.

The errors have been corrected in the PDF and HTML versions of this article.

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Gad Getz or Margaret A. Shipp.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chapuy, B., Stewart, C., Dunford, A.J. et al. Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 24, 1290–1291 (2018). https://doi.org/10.1038/s41591-018-0097-4

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing